The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARGENX SE SPONSORED ADR 04016X101   27,394,317 73,526 SH   SOLE   73,526 0 0
ASTRIA THERAPEUTICS INC COM 04635X102   25,288,580 1,901,397 SH   SOLE   1,901,397 0 0
AXSOME THERAPEUTICS INC COM 05464T104   124,078,387 2,011,647 SH   SOLE   2,011,647 0 0
BEIGENE LTD SPONSORED ADR 07725L102   51,607,150 239,443 SH   SOLE   239,443 0 0
COGENT BIOSCIENCES INC COM 19240Q201   29,769,340 2,758,975 SH   SOLE   2,758,975 0 0
DBV TECHNOLOGIES SA SPONSORED ADR 23306J101   11,939,789 7,064,964 SH   SOLE   7,064,964 0 0
ENLIVEN THERAPEUTICS INC COM 29337E102   42,156,142 1,924,938 SH   SOLE   1,924,938 0 0
GERON CORP COM 374163103   15,416,457 7,104,358 SH   SOLE   7,104,358 0 0
MERUS N V COM N5749R100   6,889,604 374,435 SH   SOLE   374,435 0 0
NUVALENT INC COM 670703107   75,256,396 2,884,492 SH   SOLE   2,884,492 0 0
TERNS PHARMACEUTICALS INC COM 880881107   24,153,600 2,040,000 SH   SOLE   2,040,000 0 0
THESEUS PHARMACEUTICALS INC COM 88369M101   16,567,158 1,865,671 SH   SOLE   1,865,671 0 0
TREVI THERAPEUTICS INC COM 89532M101   10,538,553 5,696,515 SH   SOLE   5,696,515 0 0
TYRA BIOSCIENCES INC COM 90240B106   22,771,158 1,416,998 SH   SOLE   1,416,998 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106   62,798,774 3,127,429 SH   SOLE   3,127,429 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104   34,843,209 1,369,623 SH   SOLE   1,369,623 0 0